Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
141.6 EUR | -0.21% | -1.26% | +15.93% |
05-17 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
05-16 | AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial | MT |
- Stock Market
- Equities
- AZN Stock
- ZEG Stock
- News AstraZeneca PLC
- Analyst Reco.